FMC-NA Names Joe Turk New President for Renal Therapies Group
Joseph (Joe) Turk succeeds Mark Constanzo, who recently retired, as the new President for the Fresenius Medical Care North America Renal Therapies Group, and will now oversee the renal products and pharmaceutical operations.
Read the full article » | Posted 08-12-2021
Related Articles
- CMS Relocates ESRD Survey Procedures and Interpretive Guidance Posted 06-17-2026
- CMS announced new 5-year contracts for ESRD Networks, which started May 1 Posted 06-17-2026
- Simon Davies Discusses the Role of PD in Expanding Dialysis Acess Posted 05-15-2026
- Less Home Dialysis and Transplant in Pediatric Patients Transitioning to Adult Clinics Posted 05-15-2026